Victor Javier
@vjsanchez.bsky.social
Associate Professor at UFV. Head of the Molecular Oncology Group. Hospital 12 de Octubre, Pancreatic Cancer, 🧪🔬Epigenetics, Therapeutic targets, Python, Machine Learning, Statistics and Bioinformatics. 🖥️🧬
Pinned
Victor Javier
@vjsanchez.bsky.social
· Oct 21
"Teaching is an antidote to failure" Paul Nurse, Nobel Laureate
YouTube video by NobelPrizeII
www.youtube.com
That’s why I combine teaching with research. Wise words by Paul Nurse, Nobel Laureate. “Teaching is an antidote to failure”
www.youtube.com/watch?v=0GoF...
www.youtube.com/watch?v=0GoF...
Reposted by Victor Javier
Applications now open for CRUK Clinical Academic PhD Training Programme. Join us @icr.ac.uk and The Royal Marsden NHS Foundation Trust.
We are offering a super exciting project to investigate cytoskeletal dynamics in Circulating Tumour Cells from Breast Cancer Patients.
We are offering a super exciting project to investigate cytoskeletal dynamics in Circulating Tumour Cells from Breast Cancer Patients.
November 17, 2025 at 1:02 PM
Applications now open for CRUK Clinical Academic PhD Training Programme. Join us @icr.ac.uk and The Royal Marsden NHS Foundation Trust.
We are offering a super exciting project to investigate cytoskeletal dynamics in Circulating Tumour Cells from Breast Cancer Patients.
We are offering a super exciting project to investigate cytoskeletal dynamics in Circulating Tumour Cells from Breast Cancer Patients.
Reposted by Victor Javier
I am looking for candidates for a postdoctoral position. Are you interested in the interaction between tumor cells and their stroma, do you have experience with lipid nanoparticles? Do you like the sun, the beach and good food? If so, please contact me. #CancerResearch
November 18, 2025 at 7:49 AM
I am looking for candidates for a postdoctoral position. Are you interested in the interaction between tumor cells and their stroma, do you have experience with lipid nanoparticles? Do you like the sun, the beach and good food? If so, please contact me. #CancerResearch
Neurogenic inducers inhibit the proliferation of #PancreaticCancer by promoting tumor cell transdifferentiation 🔬 jeccr.biomedcentral.com/articles/10....
Neurogenic inducers inhibit the proliferation of pancreatic cancer by promoting tumor cell transdifferentiation - Journal of Experimental & Clinical Cancer Research
Background Tumor cell differentiation is a critical determinant of malignancy and clinical treatment selection. Pancreatic ductal adenocarcinoma (PDAC), a poorly differentiated and highly aggressive t...
jeccr.biomedcentral.com
November 17, 2025 at 3:36 PM
Neurogenic inducers inhibit the proliferation of #PancreaticCancer by promoting tumor cell transdifferentiation 🔬 jeccr.biomedcentral.com/articles/10....
Targeting the ac4C ‘Writer’ NAT10 enhances #PancreaticCancer immunotherapy via dual modulation of CD8+ T cells and tumor cells 🔬 www.nature.com/articles/s41...
Targeting the ac4C ‘Writer’ NAT10 enhances pancreatic cancer immunotherapy via dual modulation of CD8+ T cells and tumor cells - Cell Death & Disease
Cell Death & Disease - Targeting the ac4C ‘Writer’ NAT10 enhances pancreatic cancer immunotherapy via dual modulation of CD8+ T cells and tumor cells
www.nature.com
November 17, 2025 at 3:31 PM
Targeting the ac4C ‘Writer’ NAT10 enhances #PancreaticCancer immunotherapy via dual modulation of CD8+ T cells and tumor cells 🔬 www.nature.com/articles/s41...
Spatial Conformation of #PancreaticCancer Is Associated with Disease Recurrence after Curative-Intent Total Neoadjuvant Therapy 🔬 www.biorxiv.org/content/10.1...
Spatial Conformation of Pancreatic Cancer Is Associated with Disease Recurrence after Curative-Intent Total Neoadjuvant Therapy
Pancreatic ductal adenocarcinoma (PDAC) frequently recurs after total neoadjuvant therapy (TNT) and curative-intent resection. Traditional histopathologic response assessments demonstrate that major p...
www.biorxiv.org
November 17, 2025 at 3:25 PM
Spatial Conformation of #PancreaticCancer Is Associated with Disease Recurrence after Curative-Intent Total Neoadjuvant Therapy 🔬 www.biorxiv.org/content/10.1...
Single-cell Transcriptomic Profiling of Pancreatic Ductal Adenocarcinoma: Epithelial Reprogramming and Systemic Immune Exhaustion #PancreaticCancer 🔬 www.biorxiv.org/content/10.1...
www.biorxiv.org
November 17, 2025 at 3:19 PM
Single-cell Transcriptomic Profiling of Pancreatic Ductal Adenocarcinoma: Epithelial Reprogramming and Systemic Immune Exhaustion #PancreaticCancer 🔬 www.biorxiv.org/content/10.1...
EmbedWorld selected in the @ageinves.bsky.social ves.bsky.social 2025 AI Call! A collaborative initiative led by @urjc.bsky.social ky.social, with @ufvmadrid.bsky.social rid.bsky.social participation, to identify molecular subtypes in pancreatic cancer using AI. Thrilled to move forward!
November 16, 2025 at 7:32 PM
EmbedWorld selected in the @ageinves.bsky.social ves.bsky.social 2025 AI Call! A collaborative initiative led by @urjc.bsky.social ky.social, with @ufvmadrid.bsky.social rid.bsky.social participation, to identify molecular subtypes in pancreatic cancer using AI. Thrilled to move forward!
¡EmbedWorld seleccionado en la convocatoria IA 2025 de la @ageinves.bsky.social ! Iniciativa colaborativa liderada por la @urjc.bsky.social , con participación de la @ufvmadrid.bsky.social , para identificar subtipos moleculares en cáncer de páncreas usando IA. Estamos muy Felices #CáncerDePáncreas
November 16, 2025 at 7:30 PM
¡EmbedWorld seleccionado en la convocatoria IA 2025 de la @ageinves.bsky.social ! Iniciativa colaborativa liderada por la @urjc.bsky.social , con participación de la @ufvmadrid.bsky.social , para identificar subtipos moleculares en cáncer de páncreas usando IA. Estamos muy Felices #CáncerDePáncreas
Reposted by Victor Javier
🚀 Looking for a motivated postdoc in molecular biology! Apply for a Juan de la Cierva 2025 fellowship and join R'n'R lab in Madrid.
📅 PhD Jan'24–Dec'25
🔍 DNA replication & biotech #piMDA #WGA, bacterial genomics & defense
👉 rnrlab.github.io
#Postdoc #JdC2025
@iib.uam.es @uammedicina.bsky.social
📅 PhD Jan'24–Dec'25
🔍 DNA replication & biotech #piMDA #WGA, bacterial genomics & defense
👉 rnrlab.github.io
#Postdoc #JdC2025
@iib.uam.es @uammedicina.bsky.social
November 7, 2025 at 5:21 PM
🚀 Looking for a motivated postdoc in molecular biology! Apply for a Juan de la Cierva 2025 fellowship and join R'n'R lab in Madrid.
📅 PhD Jan'24–Dec'25
🔍 DNA replication & biotech #piMDA #WGA, bacterial genomics & defense
👉 rnrlab.github.io
#Postdoc #JdC2025
@iib.uam.es @uammedicina.bsky.social
📅 PhD Jan'24–Dec'25
🔍 DNA replication & biotech #piMDA #WGA, bacterial genomics & defense
👉 rnrlab.github.io
#Postdoc #JdC2025
@iib.uam.es @uammedicina.bsky.social
🎉 Huge success at our seminar on melanoma & brain metastasis! Thanks to Dr. Eva Pérez Guijarro from IIBM Madrid for sharing her research on tumor plasticity & immunotherapy. Great turnout from students & researchers. Moving science forward! 🔬✨ @iib.uam.es @ufvmadrid.bsky.social
November 12, 2025 at 3:21 PM
🎉 Huge success at our seminar on melanoma & brain metastasis! Thanks to Dr. Eva Pérez Guijarro from IIBM Madrid for sharing her research on tumor plasticity & immunotherapy. Great turnout from students & researchers. Moving science forward! 🔬✨ @iib.uam.es @ufvmadrid.bsky.social
Reposted by Victor Javier
IT'S HAPPENING! 💥 I'm psyched to launch the collaboration between @qedscience.bsky.social & @openrxiv.bsky.social @biorxivpreprint.bsky.social! Preprint + q.e.d = your science is out there, and anyone can appreciate it. Let's care about making discoveries, and not on “getting published” (1/3) 👇
November 6, 2025 at 2:49 PM
IT'S HAPPENING! 💥 I'm psyched to launch the collaboration between @qedscience.bsky.social & @openrxiv.bsky.social @biorxivpreprint.bsky.social! Preprint + q.e.d = your science is out there, and anyone can appreciate it. Let's care about making discoveries, and not on “getting published” (1/3) 👇
Contrastive virtual staining enhances deep learning‐based PDAC subtyping from H&E‐stained tissue cores pathsocjournals.onlinelibrary.wiley.com/doi/10.1002/... #PancreaticCancer
Contrastive virtual staining enhances deep learning‐based PDAC subtyping from H&E‐stained tissue cores
Pancreatic ductal adenocarcinoma (PDAC) subtyping typically relies on immunohistochemistry (IHC) staining for critical markers like HNF1A and KRT81, a labor-intensive manual staining process that int...
pathsocjournals.onlinelibrary.wiley.com
November 6, 2025 at 10:42 AM
Contrastive virtual staining enhances deep learning‐based PDAC subtyping from H&E‐stained tissue cores pathsocjournals.onlinelibrary.wiley.com/doi/10.1002/... #PancreaticCancer
Elevated levels of cleaved soluble forms of urokinase-type Plasminogen Activator Receptor are associated with poor survival in advanced #PancreaticCancer. www.sciencedirect.com/science/arti...
Elevated levels of cleaved soluble forms of urokinase-type Plasminogen Activator Receptor are associated with poor survival in advanced pancreatic cancer.
Different forms of urokinase plasminogen activator receptor (uPAR) in tissues and plasma are associated with poor prognosis in several types of cancer…
www.sciencedirect.com
November 6, 2025 at 10:40 AM
Elevated levels of cleaved soluble forms of urokinase-type Plasminogen Activator Receptor are associated with poor survival in advanced #PancreaticCancer. www.sciencedirect.com/science/arti...
TMEtyper: A computational method for tumor microenvironment subtyping with applications in immunotherapy www.sciencedirect.com/science/arti...
TMEtyper: A computational method for tumor microenvironment subtyping with applications in immunotherapy
The heterogeneity of the tumor microenvironment (TME) is a critical determinant of outcomes in immune checkpoint blockade (ICB) therapy. However, robu…
www.sciencedirect.com
November 6, 2025 at 10:38 AM
TMEtyper: A computational method for tumor microenvironment subtyping with applications in immunotherapy www.sciencedirect.com/science/arti...
Therapeutic Eradication of Cancer-associated Fibroblasts Inhibits in vivo progression of #PancreaticCancer www.biorxiv.org/content/10.1...
Therapeutic Eradication of Cancer-associated Fibroblasts Inhibits in vivo progression of Pancreatic Cancer
Pancreatic ductal adenocarcinoma (PDAC) remains a lethal disease with an unmet medical need. therapeutic elimination of cancer associated fibroblasts (CAFs), key drivers of tumor aggressiveness, has b...
www.biorxiv.org
November 6, 2025 at 10:26 AM
Therapeutic Eradication of Cancer-associated Fibroblasts Inhibits in vivo progression of #PancreaticCancer www.biorxiv.org/content/10.1...
Just finished differential expression analysis! What tools do you recommend for studying miRNA-regulated pathways? So far, folks suggest TargetScan, miRDB, DIANA-microT, and miRPathDB for target prediction + KEGG/GO for pathway enrichment. Any hidden gems? #miRNA #Bioinformatics #ResearchTips 🧬🖥️
November 5, 2025 at 8:31 PM
Just finished differential expression analysis! What tools do you recommend for studying miRNA-regulated pathways? So far, folks suggest TargetScan, miRDB, DIANA-microT, and miRPathDB for target prediction + KEGG/GO for pathway enrichment. Any hidden gems? #miRNA #Bioinformatics #ResearchTips 🧬🖥️
Association of tumor associated collagen signature with lymph node metastasis in pancreatic ductal adenocarcinoma #PancreaticCancer aiche.onlinelibrary.wiley.com/doi/10.1002/...
Association of tumor associated collagen signature with lymph node metastasis in pancreatic ductal adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive and fatal cancer with significant metastatic potential. Lymph node status is crucial for determining treatment options and predicting pr...
aiche.onlinelibrary.wiley.com
November 5, 2025 at 8:10 AM
Association of tumor associated collagen signature with lymph node metastasis in pancreatic ductal adenocarcinoma #PancreaticCancer aiche.onlinelibrary.wiley.com/doi/10.1002/...
DIRAS3-derived cyclic peptides disrupt KRAS-RAF interaction and KRAS nanoclustering, suppressing KRAS-driven pancreatic and ovarian tumors #PancreaticCancer www.sciencedirect.com/science/arti...
DIRAS3-derived cyclic peptides disrupt KRAS-RAF interaction and KRAS nanoclustering, suppressing KRAS-driven pancreatic and ovarian tumors
Mutations in KRAS drive 88% of pancreatic ductal adenocarcinomas (PDAC) and up to 40% of low-grade serous ovarian cancers (LGSOC), making KRAS a long-…
www.sciencedirect.com
November 5, 2025 at 8:08 AM
DIRAS3-derived cyclic peptides disrupt KRAS-RAF interaction and KRAS nanoclustering, suppressing KRAS-driven pancreatic and ovarian tumors #PancreaticCancer www.sciencedirect.com/science/arti...
m6A demethylase FTO drives pancreatic ductal adenocarcinoma tumorigenesis and metastasis through remodeling PFKM mediated glycolysis #PancreaticCancer www.nature.com/articles/s41...
m6A demethylase FTO drives pancreatic ductal adenocarcinoma tumorigenesis and metastasis through remodeling PFKM mediated glycolysis - Cell Death & Disease
Cell Death & Disease - m6A demethylase FTO drives pancreatic ductal adenocarcinoma tumorigenesis and metastasis through remodeling PFKM mediated glycolysis
www.nature.com
November 5, 2025 at 7:58 AM
m6A demethylase FTO drives pancreatic ductal adenocarcinoma tumorigenesis and metastasis through remodeling PFKM mediated glycolysis #PancreaticCancer www.nature.com/articles/s41...
A machine learning-based method to optimize the immunogenicity of human leukocyte antigen class I-restricted neoantigens academic.oup.com/bib/article/...
A machine learning-based method to optimize the immunogenicity of human leukocyte antigen class I-restricted neoantigens
Abstract. Neoantigens, arising from somatic mutations, have the potential to induce immune responses against tumor cells. As natural neoantigens that drive
academic.oup.com
November 5, 2025 at 7:56 AM
A machine learning-based method to optimize the immunogenicity of human leukocyte antigen class I-restricted neoantigens academic.oup.com/bib/article/...
@zotero.org is not running in some computers after @fedora.fosstodon.org.ap.brid.gy update. Are you planning an update? Thanks 🙏
November 2, 2025 at 1:18 PM
@zotero.org is not running in some computers after @fedora.fosstodon.org.ap.brid.gy update. Are you planning an update? Thanks 🙏
Reposted by Victor Javier
Lo de que la gente esté entendiendo mal los dislikes que van a implementar qué es? Los dislikes no te van a salir como los likes, son privados y se usarán únicamente para entrenar los feeds con algoritmo como Discover. Por favor, leed un poco, solo un poco.
Progress Update: Building Healthier Social Media - Bluesky
Over the next few months, we’ll be iterating on the systems that make Bluesky a better place for healthy conversations. Some experiments will stick, others will evolve, and we’ll share what we learn a...
bsky.social
November 2, 2025 at 12:14 PM
Lo de que la gente esté entendiendo mal los dislikes que van a implementar qué es? Los dislikes no te van a salir como los likes, son privados y se usarán únicamente para entrenar los feeds con algoritmo como Discover. Por favor, leed un poco, solo un poco.
Reposted by Victor Javier
«Si tienes un móvil Android, tienes que dejar de navegar con Chrome» loquesomos.es/si-tienes-un...
"Si tienes un móvil Android, tienes que dejar de navegar con Chrome" - LoQueSomos
Si tienes un móvil Android, tienes que dejar de navegar con Chrome, privacidad, robo de datos, nevgadores, Tor, Firefox
loquesomos.es
November 2, 2025 at 7:12 AM
«Si tienes un móvil Android, tienes que dejar de navegar con Chrome» loquesomos.es/si-tienes-un...
